Evidence map›Paper›PMID 16203092›Full record

ArticleNeuroscience letters2006

Estrogen contributes to structural recovery after a lesion.

Christopher Saenz, Reymundo Dominguez, Sonsoles de Lacalle

Abstract readComparative Study
In one paragraph

Article in Neuroscience letters, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Christopher SaenzDepartment of Biology, Pasadena City College, CA 91106, USA.
Reymundo Dominguez
Sonsoles de Lacalle
Charles R. Drew University of Medicine and Science · USPasadena City College · USUniversity of Southern California · US

Funding

Research Initiative for Scientific Enhancement (RISE)R25GM061331 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI FOSTER, KRISHNA L · 2000 to 2021
$33.1M
Charles R Drew University College of Allied Health Unde*P20MD000545 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI ORUM-ALEXANDER, GAIL · 2003 to 2007
$4.7M
ESTROGEN AND CHOLINERGIC SYSTEM INTERACTIONS IN AGINGR01AG019597 · NIA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI DE LACALLE, SONSOLES · 2000 to 2004
$1.3M
NIA NIH HHS AG19597NIA NIH HHS R01 AG019597NIGMS NIH HHS R25 GM061331NIMHD NIH HHS MD000545NIMHD NIH HHS P20 MD000545
6 · The paper itself

Abstract

Over the last decade neuroscientists have accumulated a wealth of information confirming the trophic effects of 17beta-estradiol (E2) on a variety of brain regions, such as the effects on hippocampal spine density, as well as other measures of structural reorganization. Here, we explore the hypothesis that E2 exerts a positive trophic effect on the cholinergic neurons of the basal forebrain, an area heavily implicated in memory and attentional processes. Female rats were ovariectomized at 3 months of age and lesioned with the immunotoxin 192 IgG-saporin before receiving a subcutaneous pellet containing .25 mg of estrogen or placebo, released over 60 days. The control, non-ovariectomized group was treated identically. At the end of the treatment, the brains were histologically prepared and we used image analysis procedures to evaluate changes in the dendritic arborization of surviving cholinergic neurons. As expected, infusion of the immunotoxin induced a reduction in dendritic arborization in all subjects, but was significantly different from control values only in ovariectomized rats. When differences within animals were factored in, dendritic size in ovariectomized animals treated with E2 was undistinguishable from intact controls. By contrast, in ovariectomized animals treated with placebo, dendritic length remained significantly reduced. These results suggest that E2 can not only protect but also reverse structural neurodegenerative processes in cholinergic neurons. Our data is particularly relevant in the context of female aging and postmenopausal dementia, since preserving an intact cholinergic system may be crucial to prevent at least some of the cognitive decline that occurs in Alzheimer's disease.

Indexed as

Analysis of VarianceAnimalsAntibodies, MonoclonalBrain InjuriesCholine O-AcetyltransferaseDisease Models, AnimalEstradiolFemaleFunctional LateralityImmunohistochemistryImmunotoxinsNeuronsN-Glycosyl HydrolasesOvariectomyRatsRats, Inbred F344192 IgG-saporinAntibodies, MonoclonalCholine O-AcetyltransferaseEstradiolImmunotoxinsN-Glycosyl HydrolasesReceptor, Nerve Growth FactorRibosome Inactivating Proteins, Type 1Saporins

Identifiers

PMID16203092
PMCPMC3182119
OpenAlexW2018028241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.